Literature DB >> 28612769

Monitoring medicines use to support national medicines policy development and implementation in the Asia Pacific region.

Elizabeth E Roughead1, Karma Lhazeen2, Engko Socialine3, Salmah Bahri4, Byong Joo Park5, Kathleen Holloway6.   

Abstract

Critical to the successful implementation of a national medicines strategy is evaluation of the policy and ongoing monitoring of medicine use. Methods for monitoring medicines use within countries vary depending on the country and its stage of medicines policy development and implementation. In this paper, we provide four case studies on monitoring medicines use to support national medicines policy development and implementation. Cases come from Bhutan, Indonesia, Malaysia and the Republic of Korea.

Year:  2013        PMID: 28612769     DOI: 10.4103/2224-3151.122946

Source DB:  PubMed          Journal:  WHO South East Asia J Public Health        ISSN: 2224-3151


  4 in total

1.  A Retrospective Analysis of Spontaneous Adverse Drug Reactions Reports Relating to Paediatric Patients.

Authors:  Rosliana Rosli; Long Chiau Ming; Noorizan Abd Aziz; Mohamed Mansor Manan
Journal:  PLoS One       Date:  2016-06-01       Impact factor: 3.240

2.  Assessment of Drug Use Pattern Using WHO Core Prescribing Indicators at Outpatient Settings of Governmental Hospitals in Dessie Town.

Authors:  Getnet Mengistu; Desye Misganaw; Tessema Tsehay; Belete Kassa Alemu; Kassahun Bogale
Journal:  Drug Healthc Patient Saf       Date:  2020-11-27

Review 3.  Essential Medicine Utilization and Situation in Selected Ten Developing Countries: A Compendious Audit.

Authors:  Mainul Haque
Journal:  J Int Soc Prev Community Dent       Date:  2017-07-31

4.  Investigation of prescribing behavior at outpatient settings of governmental hospitals in eastern Ethiopia: an overall evaluation beyond World Health Organization core prescribing indicators.

Authors:  Tigist Gashaw; Mekonnen Sisay; Getnet Mengistu; Firehiwot Amare
Journal:  J Pharm Policy Pract       Date:  2018-10-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.